ICU sedation, delirium & recovery

Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the consecutive stages of the COVID-19 pandemic in the Netherlands, an update

Ann Intensive CarePublished Nationwide cohort study

Authors' conclusion

The results show variation in mortality rates among critically ill COVID-19 patients across the calendar time periods that is not explained by differences in case-mix and ICU occupancy rates or by varying proportions of patients with COVID-19 as main reason for ICU admission.

Study context

Population
All COVID-19 patients admitted to an ICU in the Netherlands (National Intensive Care Evaluation (NICE) registry), February 2020-January 31, 2023
Exposure
Consecutive pandemic periods after the first wave vs first wave
Outcome
In-hospital mortality
Methodological detailsregistry-based
  • Registry-based

Main finding

As reported in the abstract

Adjusted for patient characteristics and ICU occupancy rate
Each group vs period 1Adjusted odds ratio (95% CI)
Period 6
1.01(0.88–1.16)
Period 9
0.52(0.41–0.66)

Observational data: associations, not effects.

Further findings

Proportion of SARS-CoV-2 positive patients with COVID-19 as main reason for ICU admission

Initial upsurge of the third wave
88.2%
Periods thereafter
51.7%, 37.3%, and 41.9%

In-hospital mortality restricted to patients with COVID-19 as main reason for ICU admission

Restriction did not modify the results on mortality

Original publication

Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the consecutive stages of the COVID-19 pandemic in the Netherlands, an update. Ann Intensive Care. Published 16 January 2024. doi:10.1186/s13613-023-01238-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.